Dow Gains Over 100 Points; US Producer Prices Rise 0.1% In June
Portfolio Pulse from Lisa Levin
US stocks traded higher with the Dow Jones gaining over 100 points. Producer prices for final demand in the U.S. rose 0.1% month-over-month in June. Jiuzi Holdings, Synaptogenix, and 60 Degrees Pharmaceuticals saw significant stock increases, while Viasat, Cryoport, and First Wave BioPharma experienced notable drops.
July 13, 2023 | 2:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jiuzi Holdings shares shot up 68% to $4.70 after a 1:18 reverse split.
The company's stock price increased significantly after a 1:18 reverse split, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Shares of Synaptogenix shot up 56% to $1.37 after the company's abstract highlighting Bryostatin-1 benefits in severe Alzheimer's disease was accepted for presentation.
The company's stock price increased significantly after positive news about its Alzheimer's disease treatment, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
60 Degrees Pharmaceuticals shares were up 30% to $6.89 after the company announced pricing of initial public offering at $5.30 per unit for a total of $7.5 million.
The company's stock price increased significantly after the pricing of its IPO, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Shares of Cryoport were down 28% to $14.01 after the company announced lower than expected interim second-quarter earnings, FY23 guidance.
The company's stock price dropped significantly after announcing lower than expected earnings, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
First Wave BioPharma was down 30% to $0.94 after the company said preliminary data from Phase 2 SPAN trial indicate that it is likely the primary efficacy endpoint was not achieved.
The company's stock price dropped significantly after announcing likely failure to achieve primary efficacy endpoint in its Phase 2 trial, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Viasat shares dropped 31% to $29.70 after the company reported an unexpected event that may impact ViaSat-3 Americas satellite performance.
The company's stock price dropped significantly after reporting an unexpected event that may impact its satellite performance, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100